Page 101 | Certara

Case Study

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…

CertaraMay 9, 2023

Press Coverage

The Impact of the Inflation Reduction Act on Biosimilar Uptake

In an interview with HCPLive, Maximilian Vargas, PhD, MBA, vice president of the United States…

CertaraMay 8, 2023

Blog

What is a Global Risk Mitigation Plan & how can you use it to ensure a successful drug launch?

A Global Risk Mitigation Plan (GRMP) is a critical step in drug development as it…

CertaraMay 4, 2023

Press Coverage

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

2023 guidance from FDA on dosages in oncology provides further context on expectations with Project…

CertaraMay 3, 2023

Blog

SEND Dataset Quality Control: Best Practices & Recommendations

In this blog, Senior Product Management Director Peggy Zorn explores best practices & recommendations for…

CertaraApril 25, 2023

On-Demand Webinar

How digital communication tools will revolutionize your medical conversation

Medical Affair, Market Access, and Sales & Marketing teams at most of pharmaceutical companies use…

CertaraApril 24, 2023

Press Coverage

Overcoming CMC challenges in cell and gene therapy: part II

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven…

CertaraApril 22, 2023

Case Study

Using MBMA to run virtual “head-to-head trials”

Osteoporosis is common in post-menopausal women. The long-term sequelae of osteoporosis include bone fractures, particularly…

CertaraApril 21, 2023

Blog

Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech

The regulatory environment for Pharma and Med Tech creates business challenges for digital engagement. Many…

CertaraApril 21, 2023

Conference

AMWA 2025 Medical Writing and Communications Conference

–

CertaraApril 20, 2023

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

The Impact of the Inflation Reduction Act on Biosimilar Uptake

What is a Global Risk Mitigation Plan & how can you use it to ensure a successful drug launch?

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

SEND Dataset Quality Control: Best Practices & Recommendations

How digital communication tools will revolutionize your medical conversation

Overcoming CMC challenges in cell and gene therapy: part II

Using MBMA to run virtual “head-to-head trials”

Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech

AMWA 2025 Medical Writing and Communications Conference

Newsletter sign up

Quick links

Solutions

Contact